Your email adddress is safe with us. View our Privacy policy.
New 5-in-1 pediatric vaccine reduces shots
The first 5-in-1 pediatric combination vaccine -- approved for use in infants and children 6 weeks through 4 years of age -- contains immunization against invasive disease due to Haemophilus influenza type b, diphtheria, tetanus, pertussis and poliomyelitis.
Pentacel vaccine is approved for administration as a four-dose series at 2, 4, 6 and 15 to 18 months of age. The first dose may be given as early as 6 weeks of age.
The current recommended childhood immunization schedule of the U.S. Centers for Disease Control and Prevention in Atlanta says up to 23 injections are needed by the time a child reaches 18 months of age with single-entity vaccines, however, the use of the Pentacel vaccine could reduce that number of shots by seven, said Wayne Pisano, president and chief executive officer of Sanofi Pasteur.
Pisano said the current recommended childhood immunization schedule of the U.S. Centers for Disease Control and Prevention in Atlanta says up to 23 injections are needed by the time a child reaches 18 months of age with single-entity vaccines.
However the use of the Pentacel vaccine -- already approved in Canada for a decade -- could reduce that number of shots by seven.
Copyright 2008 by United Press International
This news arrived on: 06/23/2008
Printer Friendly Version | Send this page to a friend | Post Comment
Rate This Story:
Great - 5 - 4 - 3 - 2 - 1 - Bad
Posted Comments:
Comment archive | Comment FAQ's
![]() |
![]() |
View Health & Fitness ezine stories by date or visit the complete archive |
Featured Channel: Politics
The ArcaMax Politics channel is one of 70 content categories offered by ArcaMax Publishing on this ... |










Body Mass